Cargando…
Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice
To identify if the absence of the vasoactive intestinal peptide (VIP) gene enhances susceptibility to death from metastatic bladder cancer, two strains of mice were injected with MB49 murine bladder cancer cells. The growth and spread of the cancer was measured over a period of 4 weeks in C57BL/6 mi...
Autores principales: | Mirsaidi, Niely, Burns, Matthew P., McClain, Steve A., Forsyth, Edward, Li, Jonathan, Dukes, Brittany, Lin, David, Nahvi, Roxanna, Giraldo, Jheison, Patton, Megan, Wang, Ping, Lin, Ke, Miller, Edmund, Ratliff, Timothy, Hamidi, Sayyed, Crist, Scott, Takemaru, Ken-Ichi, Szema, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545686/ https://www.ncbi.nlm.nih.gov/pubmed/28824540 http://dx.doi.org/10.3389/fendo.2017.00162 |
Ejemplares similares
-
Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
por: Szema, Anthony M, et al.
Publicado: (2011) -
VIP Gene Deletion in Mice Causes Cardiomyopathy Associated with Upregulation of Heart Failure Genes
por: Szema, Anthony M., et al.
Publicado: (2013) -
Enhanced metastatic potential in the MB49 urothelial carcinoma model
por: Liu, Yu-Ru, et al.
Publicado: (2019) -
Sex differences in the MB49 syngeneic, murine model of bladder cancer
por: White-Gilbertson, Shai, et al.
Publicado: (2016) -
VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
por: Hamidi, Sayyed A, et al.
Publicado: (2011)